drugset / Trial / NCT01287533

Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-term Steroids

NCT01287533

Phase 4 Completed 167 enrolled Yeong-Wook Song
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This study was to investigate the efficacy of oral monthly ibandronate in the management of glucocorticoid induced osteoporosis in women with rheumatoid arthritis.

Timeline

Start
2010-04
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibandronate Other / unclassified 150 mg Oral